Pascale Tubert-Bitter

Summary

Country: France

Publications

  1. ncbi request reprint Sample size calculations for risk equivalence testing in pharmacoepidemiology
    P Tubert-Bitter
    INSERM Unite 472, Epidémiologie et Biostatistique, 16 Avenue Paul Vaillant Couturier, 94807 Cedex, Villejuif, France
    J Clin Epidemiol 53:1268-74. 2000
  2. ncbi request reprint A nonparametric comparison of the effectiveness of treatments: a multivariate toxicity-penalized approach
    Pascale Tubert-Bitter
    INSERM U 472, Villejuif, France
    J Biopharm Stat 15:129-42. 2005
  3. ncbi request reprint Two-treatment comparison based on joint toxicity and efficacy ordered alternatives in cancer trials
    Alexia Letierce
    INSERM U472, 16, avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
    Stat Med 22:859-68. 2003
  4. ncbi request reprint Testing independence between two Poisson-generated multinomial variables in case-series and cohort studies
    Mounia Hocine
    Institut National de la Sante et de la Recherche Medicale, Unité 472, Villejuif, France
    Stat Med 24:4035-44. 2005
  5. ncbi request reprint The safety of drugs for OTC use: what evidence is required for an NSAID switch?
    Thomas M MacDonald
    Medicines Monitoring Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
    Pharmacoepidemiol Drug Saf 11:577-84. 2002
  6. ncbi request reprint An easy to use method to approximate Poisson confidence limits
    Bernard Begaud
    Department de Pharmacologie, Universite Victor Segalen, 33076 Bordeaux Cedex, France
    Eur J Epidemiol 20:213-6. 2005
  7. ncbi request reprint Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001)
    Frantz Thiessard
    EA3676, IFR99, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux Cedex, France
    Drug Saf 28:731-40. 2005
  8. ncbi request reprint A combined superiority and non-inferiority approach to multiple endpoints in clinical trials
    Daniel A Bloch
    HRP Biostatistics, Stanford University, Stanford, CA 94305, U S A
    Stat Med 26:1193-207. 2007
  9. ncbi request reprint Detection of emerging diseases in occupational health: usefulness and limitations of the application of pharmacosurveillance methods to the database of the French National Occupational Disease Surveillance and Prevention network (RNV3P)
    Vincent Bonneterre
    Faculte de Medecine, Domaine de la Merci, 38706 La Tronche Cedex, France
    Occup Environ Med 65:32-7. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Sample size calculations for risk equivalence testing in pharmacoepidemiology
    P Tubert-Bitter
    INSERM Unite 472, Epidémiologie et Biostatistique, 16 Avenue Paul Vaillant Couturier, 94807 Cedex, Villejuif, France
    J Clin Epidemiol 53:1268-74. 2000
    ..This approach is the appropriate way to conclude equivalence, rather than the commonly used approach of difference testing and concluding equivalence when the null hypothesis of equality is not rejected...
  2. ncbi request reprint A nonparametric comparison of the effectiveness of treatments: a multivariate toxicity-penalized approach
    Pascale Tubert-Bitter
    INSERM U 472, Villejuif, France
    J Biopharm Stat 15:129-42. 2005
    ..Data from a randomized clinical trial of patients with metastatic nonseminomatous germ cell tumors are used to illustrate the method...
  3. ncbi request reprint Two-treatment comparison based on joint toxicity and efficacy ordered alternatives in cancer trials
    Alexia Letierce
    INSERM U472, 16, avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
    Stat Med 22:859-68. 2003
    ..Our approach is illustrated with a multi-centre randomized clinical trial involving patients with metastatic non-seminomatous germ cell tumours...
  4. ncbi request reprint Testing independence between two Poisson-generated multinomial variables in case-series and cohort studies
    Mounia Hocine
    Institut National de la Sante et de la Recherche Medicale, Unité 472, Villejuif, France
    Stat Med 24:4035-44. 2005
    ..Simulations for checking the validity of the test concerning the type I error and the power properties are presented. The test is illustrated using data from a cohort on antibiotics bacterial resistance in schoolchildren...
  5. ncbi request reprint The safety of drugs for OTC use: what evidence is required for an NSAID switch?
    Thomas M MacDonald
    Medicines Monitoring Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
    Pharmacoepidemiol Drug Saf 11:577-84. 2002
    ..2 with at least 90% power for an event rate of 5%. An example of a possible pharmacy-based randomized study design to demonstrate safety equivalence of OTC analgesics is given...
  6. ncbi request reprint An easy to use method to approximate Poisson confidence limits
    Bernard Begaud
    Department de Pharmacologie, Universite Victor Segalen, 33076 Bordeaux Cedex, France
    Eur J Epidemiol 20:213-6. 2005
    ..It allows computation of Poisson confidence limits both for count or rates and proportions...
  7. ncbi request reprint Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001)
    Frantz Thiessard
    EA3676, IFR99, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux Cedex, France
    Drug Saf 28:731-40. 2005
    ..The objective of this study is to describe the characteristics of the reports and the reporting trends in the French pharmacovigilance spontaneous reporting database from 1986 to 2001...
  8. ncbi request reprint A combined superiority and non-inferiority approach to multiple endpoints in clinical trials
    Daniel A Bloch
    HRP Biostatistics, Stanford University, Stanford, CA 94305, U S A
    Stat Med 26:1193-207. 2007
    ....
  9. ncbi request reprint Detection of emerging diseases in occupational health: usefulness and limitations of the application of pharmacosurveillance methods to the database of the French National Occupational Disease Surveillance and Prevention network (RNV3P)
    Vincent Bonneterre
    Faculte de Medecine, Domaine de la Merci, 38706 La Tronche Cedex, France
    Occup Environ Med 65:32-7. 2008
    ..To test data mining methods used in pharmacosurveillance in order to identify potential emerging disease-nuisance associations in the national occupational disease surveillance and prevention network (RNV3P) database...